2m 2m 2m 2m 2m 2m 2m
PALISADE BIO (PALI)
NASDAQ
$1.88-$0.05 (-2.64%)
Price as of Jun 03, 2026 7:57 PM EDT- $368.0MMarket Cap
- 152.72%1-Year Change
- BiotechnologyIndustry
PALISADE BIO (PALI)
$1.88-$0.05 (-2.64%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 0 N/A | 0 -100.00% | 250,000 N/A | N/A N/A | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 0 N/A | 0 -100.00% | 250,000 N/A | 0 N/A | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -10.2M +12.46% | -9.1M +31.48% | -6.9M +5.28% | -6.5M -79.88% | |
Depreciation and Amortization Expense | 3,000 0.00% | 3,000 -25.00% | 4,000 +33.33% | 3,000 +50.00% | |
Total Operating Expenses | 18.1M +21.52% | 14.9M +11.55% | 13.3M -15.27% | 15.7M -62.44% | |
Operating Profit | -18.1M +21.52% | -14.9M +13.69% | -13.1M -16.86% | -15.7M -62.44% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | -12,000 -20.00% | -15,000 +15.38% | -13,000 -99.46% | |
Interest Income and Expense and Net | 0 +100.00% | -12,000 -20.00% | -15,000 +15.38% | -13,000 -99.46% | |
Total Nonoperating Income and Expense | 1.3M +202.85% | 421,000 -45.32% | 770,000 -47.30% | 1.5M -90.41% | |
Income before Taxes | -18.1M +25.06% | -14.4M +17.23% | -12.3M -15.34% | -14.5M -45.34% | |
Income Taxes | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -16.8M +16.23% | -14.4M +17.38% | -12.3M -13.74% | -14.3M -46.42% | |
Net Income from Continuing Operations Applicable to Common | -16.8M +16.23% | -14.4M +17.23% | -12.3M -15.34% | -14.5M -54.16% | |
Basic EPS and Net Income | -0.30 -97.06% | -10.19 +466.11% | -1.80 -89.11% | -16.53 +477.97% | |
Diluted EPS and Net Income | -0.30 -97.06% | -10.19 +466.11% | -1.80 -89.11% | -16.53 +387.61% | |
Basic Weighted Average Shares | 55.7M +3,830.18% | 1.4M -79.29% | 6.8M +677.02% | 880,311 -90.54% | |
Diluted Weighted Average Shares | 55.7M +3,830.18% | 1.4M -79.29% | 6.8M +677.02% | 880,311 -90.58% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 133.4M +1,258.16% | 9.8M -21.00% | 12.4M +0.40% | 12.4M +17.99% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 133.4M +1,258.16% | 9.8M -21.00% | 12.4M +0.40% | 12.4M +17.99% | |
Total Current Assets | 134.2M +1,179.03% | 10.5M -21.26% | 13.3M -9.54% | 14.7M +19.06% | |
Accumulated Depreciation | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | 0 -100.00% | 3,000 -70.00% | 10,000 0.00% | 10,000 +233.33% | |
Total Long-Term Assets | 68,000 -75.09% | 273,000 -44.29% | 490,000 -29.39% | 694,000 +23,033.33% | |
Total Assets | 134.3M +1,134.78% | 10.9M -22.57% | 14.1M -10.85% | 15.8M +25.98% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 4.6M +43.26% | 3.2M +25.14% | 2.6M -14.14% | 3.0M +20.67% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 62,000 +3,000.00% | 2,000 -97.83% | 92,000 -66.18% | 272,000 -89.74% | |
Total Liabilities | 5.0M +46.52% | 3.4M +23.69% | 2.7M -16.60% | 3.3M -36.20% | |
Retained Earnings | -152.7M +12.34% | -135.9M +11.88% | -121.5M +11.28% | -109.2M +15.37% | |
Total Stockholders Equity | 129.4M +1,626.91% | 7.5M -33.78% | 11.3M -9.34% | 12.5M +69.44% | |
Total Shares Outstanding | 159.4M +5,658.92% | 2.8M -70.14% | 9.3M +214.88% | 2.9M -79.32% | |
Cash Flow | |||||
Cash from Operating Activities | -10.8M -11.04% | -12.2M +9.52% | -11.1M -16.67% | -13.4M -9.56% | |
Capital Expenditures | N/A N/A | 0 -100.00% | 4,000 -60.00% | 10,000 N/A | |
Cash from Investing Activities | N/A N/A | 0 +100.00% | -4,000 -60.00% | -10,000 -81.48% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 134.4M +1,303.05% | 9.6M -14.34% | 11.2M -26.69% | 15.3M -38.00% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | N/A N/A | N/A N/A | -5,228.00% N/A | N/A N/A | |
Return on Assets | -23.11% -80.05% | -115.82% +40.37% | -82.51% -18.20% | -100.87% -51.57% | |
Return on Equity | -24.52% -84.03% | -153.55% +48.51% | -103.40% -28.06% | -143.72% -53.74% | |
Revenue Growth | N/A N/A | -100.00% N/A | N/A N/A | N/A N/A | |
Current Ratio | 28.95 +792.78% | 3.24 -37.08% | 5.15 +5.37% | 4.89 -1.33% | |
Cash Ratio | 28.77 +848.02% | 3.03 -36.87% | 4.81 +16.93% | 4.11 -2.22% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow